Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer

Lung Cancer

Volumn 34, Issue SUPPL. 4, 2001, Pages 25-30

  Rinaldi, Massimo ^a   Crino L ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Gemcitabine; Neoadjuvant chemotherapy; NSCLC

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; NAVELBINE; PACLITAXEL; TOPOTECAN; VINDESINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA AND VOMITING; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 0035195446     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00388-9     Document Type: Article

References (24)

1. The role of surgery in N2 lung cancer
2. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients
3. Induction chemotherapy with mitomycin, vindesin and cisplatin for stage III unresectable non small cell lung cancer: results of the Toronto phase II trial
4. A phase II trial of combined chemotherapy and surgery in stage IIIA non small cell lung cancer
5. A phase III comparison of 2best local-regional therapy with or without chemotherapy for stage IIIA, T1-3N2
6. Multimodality treatment of stage IIIA non small cell lung carcinoma: a critical review of the literature and strategies for future research
7. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis
8. Preresectional chemotherapy in stage IIIA non small cell lung cancer: definitive analysis of a randomized controlled trial
9. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non small cell lung cancer
10. Phase III trial of neo-adjuvant chemotherapy (NCT) in resectable stage I (except T1N0), II, IIIa non samll cell lung cancer: The French experience
11. New chemotherapeutic agents prolong survival and improve quality of life in non small cell lung cancer: a review of the literature and future directions
12. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non small cell lung cancer
13. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non small cell lung cancer. A randomized phase III study of the Italian Lung Cancer Project
14. Phase III trial on gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non small cell lung cancer
15. Phase II study of gemcitabine plus cisplatin as induction regimen for patients with stage IIIA-IIIB non small cell lung cancer
16. A phase II feasibility trial of gemcitabine and ciplatin in locally advanced non small cell lung cancer
17. Induction chemotherapy with gemcitabine and cisplatin in locally advanced stage III non small cell lung cancer. A phase II study
18. A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy (indCT) and concomitant cmeoradiotherapy (XRT) for unresectable stage III non small cell lung cancer (NSCLC) (CALGB Study 9431)
19. The EORTC LCCG: phase II study of gemcitabine plus cisplatin as induction regimen for patients with stage IIIA non small cell lung cancer by the EORTC lung cancer cooperative group (EORTC 08955)
20. Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB non small cell lung cancer (NSCLC): A mono-institutional phase II study with a 21 days schedule
21. Preoperative chemotherapy (CHT) with cisplatin and gemcitabine in locally advanced (LA), unresectable non small cell lung cancer (NSCLC)
22. Induction chemotherapy with gemcitabine, docetaxel, and cisplatin (GDP) in patients with non small cell lung cancer (NSCLC): phase I results
23. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. Bimodality Lung Oncology Team
24. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European Organisation for Research and Treatment of Lung Cancer. Lung Cancer Cooperative group (EORTC 08955)